Abbvie Inc. Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Abbvie Inc.
Patents: | 63 |
Tradenames: | 4 |
Ingredients: | 4 |
BLAs: | 4 |
Biologic Drugs for Abbvie Inc.
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Inc. | SURVANTA | beractant | Suspension | 020032 | 1991-07-01 | ⤷ Try a Trial | |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 2009-04-30 | ⤷ Try a Trial | |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 2002-12-31 | 6,805,686 | ⤷ Try a Trial |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 2002-12-31 | 8,231,876 | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |